Chelation
As we age, our bodies undergo an oxidation process contributed by free radicals which are obtained normally during metabolism or through environmental factors such as pollution, radiation, cigarette smoke and herbicides.
Chelation therapy is used as a treatment for acute mercury, iron, arsenic, lead, uranium, plutonium and other forms of toxic metal poisoning. The chelating agent may be administered intravenously, intramuscularly or orally, depending on the agent and the type of poisoning. Several chelating agents are available, having different affinities for different metals.
- EDTA
The amino acid, EDTA (ethylene-diamine-tetra-acetic acid) can be administered by slow intravenous infusion, as well as by oral or suppository form for lead and other heavy metal poisoning. EDTA's most important benefit seems to be that it greatly reduces the ongoing production of free radicals within the body by removing accumulations of metallic catalysts and toxins which accumulate at sites in the body as a person grows older and which speeds the aging process.
- DMPS
DMPS (2,3 dimercaptopropane sulfonate) is a synthetic amino acid chelating agent of toxic heavy metals including mercury. DMPS chelation usually takes 20-30 minutes compared to the 3-4 hours to administer EDTA chelation.
- DMSA
DMSA (meso-2,3 dimercaptosuccinic acid) is an oral form of chelation therapy which is a highly effective but gentle form of chelation. DMSA binds with metals such as lead, arsenic and mercury.
-
Plaquex® Formula (compounded)
Plaquex® contains essential phospholipids (EPL), a highly purified phosphatidylcholine fraction isolated from soybeans. The essential phospholipids correspond to endogenous phosphatidylcholine in its chemical structure, but are distinguished by their very high content of polyunsaturated fatty acids. Linoleic acid accounts for approximately 70% and is also termed polyenylphosphatidylcholine (PPC).
Compounded Plaquex® is administered by slow intravenous infusion and is indicated for: hyperlipoproteinaemia, atherosclerosis (irrespective of site), vascular diseases (especially those associated with diabetes mellitus), prevention and treatment of fat embolism, kidney disease, liver disease and aging. The compounded Plaquex® formula is very well tolerated even during long-term treatment. For additional information and studies for Plaquex®, please visit: www.plaquex.net.
To speak to a pharmacist regarding ompounded Plaquex®, call 1.800.723.7455.
To place an order for Plaquex
®, please
click here for order form. Order forms can be
faxed to 1.800.238.8239.
AnazaoHealth provides chelating agents, EDTA (Disodium, Dihydrate, USP) DMPS and DMSA as well as numerous minerals and vitamins. For other chelating agents, please contact your AnazaoHealth pharmacist at 1-800-723-7455.
Plaquex® is a registered trademark of Biorica International Corporation, © 2009.